Contact: Mary Beth O'Leary
Caption: Neural stem cells generated from iPS cells derived from a patient with Alzheimer’s disease. Once established such neural stem cells can be used to continuously generate neurons for drug testing and disease modeling. Depicted is an immunofluorescence staining where proteins characteristic of neural stem cells are labeled with fluorescing antibodies (Nestin in green, Dach1 in red). The cells show a rosette-like growth pattern, which is typical for early neural stem cells.
Credit: Stem Cell Reports, Mertens et al.
Usage Restrictions: Credit Required
Related news release: New study explains why promising dementia drugs failed in clinical trials